Advertisement
YOU ARE HERE: LAT HomeCollectionsBeckman Coulter Inc
IN THE NEWS

Beckman Coulter Inc

FEATURED ARTICLES
BUSINESS
July 27, 1999
Beckman Coulter Inc.: The Fullerton provider of instrument systems and products for laboratory use reported that net income for the second quarter climbed to $25.9 million, or 87 cents a share, from $9.5 million, or 32 cents a share, for the 1998 second quarter. Sales advanced 3% to $446.2 million from $434.7 million.
ARTICLES BY DATE
BUSINESS
February 9, 2008 | From Reuters
Beckman Coulter Inc. on Friday posted a better-than-expected fourth-quarter profit, helped by stronger demand for its medical diagnostic tests. "What this highlights is that clinical diagnostics is a very steady business," said Quintin Lai, an analyst with financial services firm Robert W. Baird & Co. "It's not a cyclical business, so all of these macroeconomic issues don't affect it. People still get sick and need treatment."
Advertisement
BUSINESS
May 23, 1999 | (Dow Jones)
Beckman Coulter Inc. said Dennis K. Wilson plans to retire this summer as chief financial officer and vice president. Amin I. Khalifa was named chief financial officer and vice president of the Fullerton provider of instrument systems, effective June 1. Khalifa was previously chief financial officer, agricultural sector, for Monsanto Co.
BUSINESS
October 31, 2007 | From Times Wire Services
Shares of Beckman Coulter Inc., a maker of medical diagnostic tests, fell after revenue missed analysts' estimates because an equipment glitch delayed instrument production and university orders declined. Beckman Coulter shares declined $2.47, or 3.4%, to $70.14, its biggest one-day fall since Aug. 9. Before Tuesday, Fullerton-based Beckman Coulter had risen 21% this year.
BUSINESS
February 18, 2006 | From Bloomberg News
Beckman Coulter Inc., a Fullerton-based maker of medical-laboratory equipment and diagnostic tests, said fourth-quarter profit plunged 70% because of rising costs and a change in its accounting for leasing revenue. Net income fell to $17.8 million, or 28 cents a share, from $59.8 million, or 91 cents, a year earlier. Sales fell 5% to $655.5 million.
BUSINESS
July 26, 2000
Beckman Coulter Inc. said Tuesday that it has signed an agreement to provide the nation's largest health care alliance with hematology instrument systems and supplies under a contract valued at $35 million a year. The Fullerton medical instruments maker announced that it will supply the products to Premier Inc., which consists of 957 health care facilities nationwide and is affiliated with 900 others.
BUSINESS
July 19, 2001
Medical device maker Beckman Coulter Inc. said it has acquired an Austrian company that will help Beckman customers automate processes in drug discovery, protein studies and genomics. The Fullerton company did not disclose the purchase price for Anthos Labtec Instruments G.m.b.H. in Salzburg. Beckman stock lost 4 cents to close at $44.66 a share on the New York Stock Exchange.
BUSINESS
February 24, 2000
Beckman Coulter Inc., a Fullerton medical instruments maker, said Wednesday that the company has signed a contract for its hematology systems with an Illinois purchasing organization that represents 289 acute care facilities throughout North America. The contract with Consorta in Rolling Meadows, Ill., is expected to bring in about $20 million in hematology business to Beckman over the next three years, with two one-year renewal options. The contract is effective March 1.
BUSINESS
October 3, 2006 | From Bloomberg News
Beckman Coulter Inc. said it would buy Lumigen Inc., a maker of chemicals used in diagnostics and scientific research, for $185 million in cash. The transaction is expected to have no effect on Beckman Coulter's financial results this year and to add at least 2 cents a share to earnings next year, the Fullerton company said. The laboratory equipment maker accounted for 40% of Southfield, Mich.-based Lumigen's $33 million in revenue last year, the companies said.
BUSINESS
May 1, 2001
Beckman Coulter Inc., Fullerton provider of medical instruments, reported first-quarter net income of $20.3 million, or 32 cents a share, which included a charge of $3.1 million for an accounting change. A year earlier, the company earned $21 million, or 35 cents a share. Sales declined to $432.7 million, from $434.4 million, as a strong dollar trimmed sales growth overseas, the company said.
BUSINESS
August 2, 2007
Medical diagnostic test maker Beckman Coulter Inc. posted a 56% jump in second-quarter earnings on demand for its genetic testing systems. Net income increased to $69.4 million, or $1.09 a share, from $44.6 million, or 70 cents, a year earlier. Quarterly revenue rose nearly 12% to $689.7 million. Shares of Beckman Coulter gained 4 cents to $70.70.
BUSINESS
March 26, 2007 | Dawn C. Chmielewski, Times Staff Writer
Beckman Coulter Inc., a Fullerton company that makes testing instruments used in hospital labs, announced Sunday that it would acquire another biomedical firm, Biosite Inc., for $1.55 billion. In a combination that would strengthen its position in the medical diagnostic field, Beckman said it would acquire all the San Diego company's stock in a cash offer of $85 a share -- a 53% premium over Biosite's closing stock price of $55.38 on Friday.
BUSINESS
November 2, 2006 | From the Associated Press
Beckman Coulter Inc. said third-quarter profit jumped 31%, mainly on proceeds from the sale of its stake in Agencourt Bioscience Corp. in July and a legal settlement. The Fullerton company earned $47.4 million, or 74 cents a share, compared with $36.2 million, or 56 cents, a year earlier. Revenue rose 6% to $631.2 million. Excluding the sale, the company's profit would have slipped to 28 cents a share, as charges including a $27.5-million payment to Roche Diagnostic Corp.
BUSINESS
October 3, 2006 | From Bloomberg News
Beckman Coulter Inc. said it would buy Lumigen Inc., a maker of chemicals used in diagnostics and scientific research, for $185 million in cash. The transaction is expected to have no effect on Beckman Coulter's financial results this year and to add at least 2 cents a share to earnings next year, the Fullerton company said. The laboratory equipment maker accounted for 40% of Southfield, Mich.-based Lumigen's $33 million in revenue last year, the companies said.
BUSINESS
August 3, 2006 | From Reuters
Beckman Coulter Inc. said its second-quarter profit fell on higher expenses and a decline in sales in Japan and China. The Fullerton maker of laboratory equipment, genetic testing kits and products used in drug discovery posted net income of $44.6 million, or 70 cents a share, down from $55.2 million, or 85 cents, a year ago. Sales fell to $616.3 million from $618.8 million last year. Beckman revised its outlook downward for the rest of the year to reflect slow growth in Asia.
BUSINESS
July 18, 2006
Beckman Coulter Inc., a Fullerton-based maker of medical instruments whose audit committee had been reviewing claims by a former employee related to accounting issues, said that the committee found no accounting irregularities and that no adjustments were needed to its financial statements.
BUSINESS
October 20, 1998
Beckman Coulter Inc., the Fullerton provider of instrument systems and products for medical laboratories, said net income for the third quarter totaled $13.9 million, or 47 cents a share, which included charges and expenses associated with the acquisition of Coulter Corp. in October 1997. That was 28% lower than the $19.4 million, or 68 cents a share, posted for the 1997 third quarter. Sales were up 48% to $400.8 million from $271.6 million.
BUSINESS
November 19, 1999 | Dow Jones
Beckman Coulter Inc. said Thursday that it has agreed to provide clinical diagnostics instrumentation to the Orlando Regional Health Care Systems in a contract worth $5 million over the next five years. The Brea company said in a press release that it will install clinical chemistry systems and an automation workstation as part of the agreement. Orlando Regional is a Florida health care network.
BUSINESS
April 27, 2006 | From Bloomberg News
Applera Corp. and Beckman Coulter Inc. said they settled lawsuits over Beckman Coulter's patents for DNA sequencers and other instruments. Under the settlement, Applera's Applied Biosystems Group will make a $35-million payment to Fullerton-based Beckman Coulter, which will make a $20-million payment over 10 quarters to Applera's Celera Genomics Group, the companies said.
Los Angeles Times Articles
|